Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics

Objective Nausea and vomiting are the most distressful side effects of cytotoxic drugs in cancer patients. Antiemetics are commonly used to reduce these side effects. However, the current antiemetic efficacy is about 70–80% in patients treated with highly-emetogenic cytotoxic drugs. One of the poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Perwitasari, D. A., Gelderblom, Hans, Atthobari, Jarir, Mustofa, Mustofa, Dwiprahasto, Iwan, Nortier, Johan W. R., Guchelaar, Henk-Jan
Formato: Texto
Lenguaje:English
Publicado: Springer Netherlands 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042115/
https://www.ncbi.nlm.nih.gov/pubmed/21365391
http://dx.doi.org/10.1007/s11096-010-9454-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042115/
https://www.ncbi.nlm.nih.gov/pubmed/21365391
http://dx.doi.org/10.1007/s11096-010-9454-1

Ejemplares similares